Clinical Trials
6 trialsNCT01167114 2023-11-02
STA-9090 in Previously Treated Patients With Advanced Esophagogastric Cancer
Massachusetts General Hospital
Phase 2 Completed
NCT02389751 2019-07-24
Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01665937 2018-04-25
STA-9090 in Patients With Advanced Hepatocellular Cancer
Massachusetts General Hospital
Phase 1 Completed
NCT01554969 2016-02-22
Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal Cancer
Emory University
Phase 1 Completed
NCT01111838 2015-11-20
Clinical and Translational Study of STA-9090
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT01227018 2014-07-23
PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer
Vanderbilt-Ingram Cancer Center
Phase 2 Terminated